Osteoporosis (OP) is a metabolic bone disease with a high incidence rate worldwide. Its
main features are decreased bone mass, increased bone fragility and deterioration of bone …

Abstract Peroxiredoxin 5 (Prdx5) is involved in pathophysiological regulation via the stress-
induced cellular response. However, its function in the bone remains largely unknown. Here …

Background Osteoporosis is a common but sub-optimally managed disease among aged
care residents. Although pharmacists are one of the key healthcare providers responsible for …

Background Osteoporosis patient education is offered in many countries worldwide. When
evaluating complex interventions like these, it is important to understand how and why the …

Introduction Minimal trauma fractures (MTFs) often occur in older patients with osteoporosis
and may be precipitated by falls risk-increasing drugs. One category of falls risk-increasing …

ABSTRACT Introduction Minimal trauma fractures (MTFs) often occur in older patients with
osteoporosis and may be precipitated by falls risk-increasing drugs. One category of falls …

Background: Effective treatment of osteoporosis is hindered by poor adherence and lack of
persistence with medical therapy. Interventions can be designed to elicit and address …

Abstract Issues Addressed Osteoporosis and poor bone health impact a large proportion of
the Australian population, but is drastically underdiagnosed and undertreated. Community …